Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
20 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Neuraxis, Inc.’s names, not what it holds today.
Patents granted
20
20 utility, 1976 to Dec 31, 2025
Granted in 2025
7
Against 2 in 2024 and 2 in 2023
Applications published
23
1 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'12'13'14'15'16'17'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Neuraxis, Inc. its own name
US, as the owner printed on each patent
8 publishedNeuraxis, LLC its own name
named as the applicant on its applications, in US
15 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Oct 28, 2025 | 12,453,865 | External auditory canal photobiomodulation and audio therapy device | Medical technology | Neuraxis, Inc. |
| Oct 28, 2025 | 12,453,864 | External auditory canal photobiomodulation device | Medical technology | Neuraxis, Inc. |
| Oct 28, 2025 | 12,453,856 | External auditory canal therapy device | Medical technology | Neuraxis, Inc. |
| Oct 21, 2025 | 12,447,332 | United states auricular nerve field stimulation device and methods for using the same | Medical technology | Neuraxis, Inc. |
| Aug 12, 2025 | 12,383,461 | Auricular peripheral nerve field stimulator and method of operating same | Medical technology | Neuraxis, Inc. |
| Jun 10, 2025 | 12,324,926 | Device and method for eradicating pathogens in nasal passages | Medical technology | Neuraxis, Inc. |
| Apr 29, 2025 | 12,285,602 | Methods of treating disease using auricular peripheral nerve field stimulation | Medical technology | Neuraxis, Inc. |
| Sep 24, 2024 | 12,097,371 | Auricular nerve field stimulation device | Medical technology | Neuraxis, Inc. |
| Jul 9, 2024 | 12,029,701 | Auricular peripheral nerve field stimulator and method of operating same | Medical technology | Neuraxis, Inc. |
| Nov 14, 2023 | 11,813,448 | Auricular nerve field stimulation device and methods for using the same | Medical technology | Neuraxis, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Jul 24, 2025 | 2025/0235691 | METHODS OF TREATING DISEASE USING AURICULAR PERIPHERAL NERVE FIELD STIMULATION | Medical technology | Neuraxis, LLC |
| Sep 26, 2024 | 2024/0315923 | AURICULAR PERIPHERAL NERVE FIELD STIMULATOR AND METHOD OF OPERATING SAME | Medical technology | Neuraxis, LLC · patent 12,383,461 granted from it |
| Feb 1, 2024 | 2024/0033505 | METHODS OF TREATING DISEASE USING AURICULAR PERIPHERAL NERVE FIELD STIMULATION | Medical technology | Neuraxis, LLC · patent 12,285,602 granted from it |
| Aug 3, 2023 | 2023/0241375 | AURICULAR NERVE FIELD STIMULATION DEVICE AND METHODS FOR USING THE SAME | Medical technology | Neuraxis, LLC · patent 12,447,332 granted from it |
| Jun 22, 2023 | 2023/0190577 | AURICULAR PERIPHERAL NERVE FIELD STIMULATOR AND METHOD OF OPERATING SAME | Medical technology | Neuraxis, LLC · patent 12,029,701 granted from it |
| Dec 8, 2022 | 2022/0387817 | DEVICE AND METHOD FOR ERADICATING PATHOGENS IN NASAL PASSAGES | Medical technology | Neuraxis, LLC · patent 12,324,926 granted from it |
| Nov 3, 2022 | 2022/0347474 | EXTERNAL AUDITORY CANAL THERAPY DEVICE | Medical technology | Neuraxis, LLC · patent 12,453,856 granted from it |
| Aug 11, 2022 | 2022/0249860 | EXTERNAL AUDITORY CANAL PHOTOBIOMODULATION DEVICE | Medical technology | Neuraxis, LLC · patent 12,453,864 granted from it |
| Aug 4, 2022 | 2022/0241585 | AURICULAR NERVE FIELD STIMULATION DEVICE AND METHODS FOR USING THE SAME | Medical technology | Neuraxis, LLC · patent 11,813,448 granted from it |
| Jul 21, 2022 | 2022/0226654 | AURICULAR NERVE FIELD STIMULATION DEVICE | Medical technology | Neuraxis, LLC · patent 12,097,371 granted from it |
What it applied for, 2024 to 2025: Medical technology 3.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.